Lowest Price Guaranteed
Pages
217
Last Updated
July 2026
View Count
23871
1. PREFACE
1.1. Scope of the Report
1.2. Research Methodology
1.3. Key Questions Answered
1.4. Chapter Outlines
2. EXECUTIVE SUMMARY
3. INTRODUCTION
3.1. Chapter Overview
3.2. An Overview of Biosensors
3.3. Components of Biosensors
3.4. Types of Biosensors
3.5. Applications of Biosensors in Drug Discovery
3.6. Challenges Associated with Use of Biosensors in Drug Discovery
3.7. Concluding Remarks
4. MARKET LANDSCAPE
4.1. Chapter Overview
4.2. Biosensors in Drug Discovery: Overall Market Landscape
4.2.1. Analysis by Year of Establishment
4.2.2. Analysis by Company Size
4.2.3. Analysis by Location of Headquarters
4.2.4. Most Active Players: Analysis by Number of Biosensors Developed
4.2.5. Analysis by Type of Biosensor
4.2.6. Analysis by Type of Bioreceptor Used
4.2.7. Analysis by Type of Biosensor and Type of Bioreceptor Used
4.2.8. Analysis by Drug Discovery Step(s) Supported
4.2.9. Analysis by Other Applications Supported
4.2.10. Analysis by Type of Analyte
4.2.11. Analysis by Carrier Plate Format
4.2.12. Analysis by Type of Biosensor and Carrier Plate Format
4.2.13. Analysis by Sample Capacity
4.2.14. Analysis by Sample Volume
4.2.15. Analysis by Type of Detection Method Employed
4.2.16. Analysis by Type of System
5. PRODUCT COMPETITIVENESS ANALYSIS
5.1. Chapter Overview
5.2. Assumptions and Key Parameters
5.3. Methodology
5.3. Product Competitiveness Analysis: Biosensors in Drug Discovery
6. COMPANY PROFILES: BIOSENSORS DEVELOPERS FOR DRUG DISCOVERY APPLICATIONS
6.1. Chapter Overview
6.2. Agilent Technologies
6.2.1. Company Overview
6.2.2. Product Portfolio
6.2.3. Recent Developments and Future Outlook
6.3. Axion Biosystems
6.3.1. Company Overview
6.3.2. Product Portfolio
6.3.3. Recent Developments and Future Outlook
6.4. BioNavigations
6.4.1. Company Overview
6.4.2. Product Portfolio
6.4.3. Recent Developments and Future Outlook
6.5. Creoptix
6.5.1. Company Overview
6.5.2. Product Portfolio
6.5.3. Recent Developments and Future Outlook
6.6. Cytiva
6.6.1. Company Overview
6.6.2. Product Portfolio
6.6.3. Recent Developments and Future Outlook
6.7. Dynamic Biosensors
6.7.1. Company Overview
6.7.2. Product Portfolio
6.7.3. Recent Developments and Future Outlook
6.8. Malvern Panalytical
6.8.1. Company Overview
6.8.2. Product Portfolio
6.8.3. Recent Developments and Future Outlook
6.9. Microvacuum
6.9.1. Company Overview
6.9.2. Product Portfolio
6.9.3. Recent Developments and Future Outlook
6.10. Sartorius
6.10.1. Company Overview
6.10.2. Product Portfolio
6.10.3. Recent Developments and Future Outlook
6.11. Tempo Bioscience
6.11.1. Company Overview
6.11.2. Product Portfolio
6.11.3. Recent Developments and Future Outlook
7. BRAND POSITIONING ANALYSIS
7.1. Chapter Overview
7.2 Key Parameters
7.3. Methodology
7.4. Biosensor Developers for Drug Discovery Applications
7.4.1. Brand Positioning Matrix: Agilent Technologies
7.4.2. Brand Positioning Matrix: Cytiva
7.4.3. Brand Positioning Matrix: Sartorius
7.4.4. Brand Positioning Matrix: Malvern Panalytical
8. FUNDING AND INVESTMENT ANALYSIS
8.1. Chapter Overview
8.2. Types of Funding
8.3. Biosensors in Drug Discovery: Funding and Investments
8.3.1. Analysis of Funding Instances by Year
8.3.2. Analysis of Amount Invested by Year
8.3.3. Analysis of Funding Instances by Type of Funding
8.3.4. Analysis of Amount Invested by Type of Funding
8.3.5. Analysis of Funding Instances by Type of Biosensor
8.3.6. Most Active Players: Analysis by Number of Funding Instances
8.3.7. Most Active Players: Analysis by Amount Invested
8.3.8. Most Active Investors: Analysis by Number of Funding Instances
8.3.9. Analysis of Amount Invested by Geography
8.3.9.1. Analysis by Region
8.3.9.2. Analysis by Country
9. PUBLICATION ANALYSIS
9.1. Chapter Overview
9.2. Scope and Methodology
9.3. Biosensors in Drug Discovery: Publication Analysis
9.3.1. Analysis by Year of Publication
9.3.2. Analysis by Type of Publication
9.3.3. Most Popular Journals: Analysis by Number of Publications
9.3.4. Most Popular Journals: Analysis by Impact Factor
9.3.5. Analysis by Most Popular Keywords
9.3.6. Most Active Publisher: Analysis by Number of Publications
9.3.7. Most Active Affiliated Institutes: Analysis by Number of Publications
9.3.8. Analysis by Geography
10. GLOBAL EVENT ANALYSIS
10.1. Chapter Overview
10.2. Scope and Methodology
10.3. List of Global Events Related to Biosensors in Drug Discovery
10.3.1. Analysis by Year of Event
10.3.2. Analysis by Event Platform
10.3.3. Analysis by Type of Event
10.3.4. Analysis by Location of Event
10.3.5. Analysis by Evolutionary Trends in Event Agendas / Key Focus Areas
10.3.6. Most Active Organizers: Analysis by Number of Events
10.3.7. Analysis by Designation of Participants
10.3.8. Analysis by Affiliated Department of Participants
10.3.9. Analysis by Geography of Upcoming Events
11. PATENT ANALYSIS
11.1. Chapter Overview
11.2. Scope and Methodology
11.3. Biosensors in Drug Discovery: Patent Analysis
11.3.1. Analysis by Publication Year
11.3.2. Analysis by Geography
11.3.3. Analysis by CPC Symbols
11.3.4. Analysis by Emerging Focus Areas
11.3.5. Analysis by Patent Age
11.3.6. Analysis by Type of Applicant
11.3.7. Leading Industry Players: Analysis by Number of Patents
11.3.8. Leading Non-Industry Players: Analysis by Number of Patents
11.3.9. Leading Individual Assignees: Analysis by Number of Patents
11.4. Biosensors in Drug Discovery: Patent Valuation
11.5. Leading Patents: Analysis by Number of Citations
12. MARKET FORECAST AND OPPORTUNITY ANALYSIS
12.1. Chapter Overview
12.2. Forecast Methodology and Key Assumptions
12.3. Global Biosensors in Drug Discovery Market, 2022-2035
12.3.1. Biosensors in Drug Discovery Market: Distribution by Type of Biosensor, 2022 and 2035
12.3.1.1. Optical Biosensors in Drug Discovery Market, 2022-2035
12.3.1.2. Electrochemical Biosensors in Drug Discovery Market, 2022-2035
12.3.1.3. Thermal Biosensors in Drug Discovery Market, 2022-2035
12.3.1.4. Other Biosensors in Drug Discovery Market, 2022-2035
12.3.2. Biosensor in Drug Discovery Market: Distribution by Type of End User, 2022 and 2035
12.3.2.1. Biosensor in Drug Discovery Market for Academic and Research Institutes, 2022-2035
12.3.2.2. Biosensor in Drug Discovery Market for Industry Players, 2022-2035
12.3.3. Biosensor in Drug Discovery Market: Distribution by Region, 2022 and 2035
12.3.3.1. Biosensor in Drug Discovery Market in North America, 2022-2035
13.3.3.2. Biosensor in Drug Discovery Market in Europe, 2022-2035
12.3.3.3. Biosensor in Drug Discovery Market in Asia Pacific, 2022-2035
12.3.3.4. Biosensor in Drug Discovery Market in Latin America, 2022-2035
12.3.3.5. Biosensor in Drug Discovery Market in Middle East and North Africa, 2022-2035
12.3.3.6. Biosensor in Drug Discovery Market in Rest of the World, 2022-2035
13. CONCLUDING REMARKS
14. EXECUTIVE INSIGHTS
14.1. Chapter Overview
14.2. Efferent Labs
14.2.1. Company Snapshot
14.2.2. Interview Transcript: Chief Executive Officer
14.3. Montana Molecular
14.3.1. Company Snapshot
14.3.2. Interview Transcript: Chief Executive Officer
14.4. Domain Therapeutics
14.4.1. Company Snapshot
14.4.2. Interview Transcript: Associate Director R&D, Head of Biology
15. APPENDIX 1: TABULATED DATA
16. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS
Figure 2.1 Executive Summary: Overall Market Landscape
Figure 2.2 Executive Summary: Funding and Investments
Figure 2.3 Executive Summary: Publication Analysis
Figure 2.4 Executive Summary: Global Event Analysis
Figure 2.5 Executive Summary: Patent Analysis
Figure 2.6 Executive Summary: Market Forecast and Opportunity Analysis
Figure 3.1 Components of Biosensors
Figure 3.2 Electrochemical Biosensor
Figure 3.3 Thermal Biosensor
Figure 3.4 Optical Biosensor
Figure 3.5 Piezo-electric Biosensor
Figure 3.4 Resonant Biosensor
Figure 4.1 Biosensor Developers for Drug Discovery Applications: Distribution by Year of Establishment
Figure 4.2 Biosensor Developers for Drug Discovery Applications: Distribution by Company Size
Figure 4.3 Biosensor Developers for Drug Discovery Applications: Distribution by Location of Headquarters (Region-wise)
Figure 4.4 Biosensor Developers for Drug Discovery Applications: Distribution by Location of Headquarters (Country-wise)
Figure 4.5 Biosensor Developers for Drug Discovery Applications: Distribution by Location of Headquarters and Company Size
Figure 4.6 Most Active Players: Distribution by Number of Biosensors Developed
Figure 4.7 Biosensors in Drug Discovery: Distribution by Type of Biosensor
Figure 4.8 Biosensors in Drug Discovery: Distribution by Type of Bioreceptor Used
Figure 4.9 Biosensors in Drug Discovery: Distribution by Type of Biosensor and Type of Bioreceptor Used
Figure 4.10 Biosensors in Drug Discovery: Distribution by Drug Discovery Step(s) Supported
Figure 4.11 Biosensors in Drug Discovery: Distribution by Other Applications Supported
Figure 4.12 Biosensors in Drug Discovery: Distribution by Type of Analyte
Figure 4.13 Biosensors in Drug Discovery: Distribution by Carrier Plate Format
Figure 4.14 Biosensors in Drug Discovery: Distribution by Type of Biosensor and Carrier Plate Format
Figure 4.15 Biosensors in Drug Discovery: Distribution by Sample Capacity
Figure 4.16 Biosensors in Drug Discovery: Distribution by Sample Volume
Figure 4.17 Biosensors in Drug Discovery: Distribution by Type of Detection Method Employed
Figure 4.18 Biosensors in Drug Discovery: Distribution by Type of System
Figure 5.1 Product Competitiveness Analysis: Dot Plot Analysis
Figure 5.2 Product Competitiveness Analysis: Biosensors in Drug Discovery
Figure 7.1 Biosensor Developers for Drug Discovery Applications: Brand Positioning Matrix
Figure 7.2 Brand Positioning Matrix: Agilent Technologies
Figure 7.3 Brand Positioning Matrix: Cytiva
Figure 7.4 Brand Positioning Matrix: Sartorius
Figure 7.5 Brand Positioning Matrix: Malvern Panalytical
Figure 8.1 Funding and Investment Analysis: Cumulative Year-wise Distribution of Funding Instances, 2018-2022
Figure 8.2 Funding and Investment Analysis: Cumulative Year-wise Distribution of Amount Invested, 2018-2022 (USD Million)
Figure 8.3 Funding and Investment Analysis: Distribution of Funding Instances by Type of Funding
Figure 8.4 Funding and Investment Analysis: Distribution of Amount Invested by Type of Funding (USD Million)
Figure 8.5 Funding and Investment Analysis: Distribution of Funding Instances by Type of Biosensor
Figure 8.6 Most Active Players: Distribution by Number of Funding Instances
Figure 8.7 Most Active Players: Distribution by Amount Invested (USD Million)
Figure 8.8 Most Active Investors: Distribution by Number of Funding Instances
Figure 8.9 Funding and Investment Analysis: Distribution of Amount Invested by Region (USD Million)
Figure 8.10 Funding and Investment Analysis: Distribution of Amount Invested by Country (USD Million)
Figure 9.1 Publication Analysis: Distribution by Year of Publication
Figure 9.2 Publication Analysis: Distribution by Type of Publication
Figure 9.3 Most Popular Journals: Distribution by Number of Publications
Figure 9.4 Most Popular Journals: Distribution by Impact Factor
Figure 9.5 Publication Analysis: Most Popular Keywords
Figure 9.6 Most Active Publisher: Distribution by Number of Publications
Figure 9.7 Most Active Affiliated Institutes: Distribution by Number of Publications
Figure 9.8 Publication Analysis: Distribution by Geography
Figure 10.1 Global Event Analysis: Cumulative Quarterly Trend
Figure 10.2 Global Event Analysis: Distribution by Event Platform
Figure 10.3 Global Event Analysis: Distribution by Type of Event
Figure 10.4 Global Event Analysis: Distribution by Location of Event
Figure 10.5 Global Event Analysis: Distribution by Evolutionary Trends in Event Agenda / Key Focus Area
Figure 10.6 Most Active Organizers: Distribution by Number of Events
Figure 10.7 Global Event Analysis: Distribution by Designation of Participants
Figure 10.8 Global Event Analysis: Distribution by Affiliated Department of Participants
Figure 10.9 Global Event Analysis: Geography of Upcoming Events
Figure 11.1 Patent Analysis: Distribution by Type of Patent
Figure 11.2 Patent Analysis: Distribution by Patent Publication Year
Figure 11.3 Patent Analysis: Distribution by Geography
Figure 11.4 Patent Analysis: Distribution by CPC Symbols
Figure 11.5 Patent Analysis: Emerging Focus Areas
Figure 11.6 Patent Analysis: Distribution by Patents Age
Figure 11.7 Patent Analysis: Distribution by Type of Applicant
Figure 11.8 Leading Industry Players: Distribution by Number of Patents
Figure 11.9 Leading Non-Industry Players: Distribution by Number of Patents
Figure 11.10 Leading Individual Assignees: Distribution by Number of Patents
Figure 11.11 Biosensors in Drug Discovery: Patent Valuation Analysis
Figure 12.1 Global Biosensors in Drug Discovery Market, 2022-2035 (USD Billion)
Figure 12.2 Biosensors in Drug Discovery Market: Likely Growth Scenarios
Figure 12.3 Biosensors in Drug Discovery Market: Distribution by Type of Biosensor, 2022 and 2035 (USD Billion)
Figure 12.4 Optical Biosensors in Drug Discovery Market, 2022-2035 (USD Billion)
Figure 12.5 Electrochemical Biosensors in Drug Discovery Market, 2022-2035 (USD Billion)
Figure 12.6 Thermal Biosensors in Drug Discovery Market, 2022-2035 (USD Billion)
Figure 12.7 Other Biosensors in Drug Discovery Market, 2022-2035 (USD Billion)
Figure 12.8 Biosensors in Drug Discovery Market: Distribution by Type of End User, 2022 and 2035
Figure 12.9 Biosensors in Drug Discovery Market for Academic and Research Institutes, 2022-2035 (USD Billion)
Figure 12.10 Biosensors in Drug Discovery Market for Industry Players, 2022-2035 (USD Billion)
Figure 12.11 Biosensors in Drug Discovery Market: Distribution by Region, 2022 and 2035
Figure 12.12 Biosensors in Drug Discovery Market in North America, 2022-2035 (USD Billion)
Figure 12.13 Biosensors in Drug Discovery Market in Europe, 2022-2035 (USD Billion)
Figure 12.14 Biosensors in Drug Discovery Market in Asia Pacific, 2022-2035 (USD Billion)
Figure 12.15 Biosensors in Drug Discovery Market in Latin America, 2022-2035 (USD Billion)
Figure 12.16 Biosensors in Drug Discovery Market in Middle East and North Africa, 2022-2035 (USD Billion)
Figure 12.17 Biosensors in Drug Discovery Market in Rest of the World, 2022-2035 (USD Billion)
Figure 13.1 Concluding Remarks: Market Landscape
Figure 13.2 Concluding Remarks: Funding and Investments Analysis
Figure 13.3 Concluding Remarks: Publication Analysis
Figure 13.4 Concluding Remarks: Global Event Analysis
Figure 13.5 Concluding Remarks: Patent Analysis
Figure 13.6 Concluding Remarks: Market Forecast and Opportunity Analysis
Table 4.1 Biosensors in Drug Discovery: List of Companies
Table 4.2 Biosensors in Drug Discovery: Information on Type of Biosensor, Bioreceptor used, Drug Discovery Step(s) and Other Applications Supported
Table 4.3 Biosensors in Drug Discovery: Information on Type of Analyte
Table 4.4 Biosensors in Drug Discovery: Information on Carrier Plate Format, Sample Capacity, Sample Volume, Type of Detection Method Employed and Type of System
Table 6.1 Leading Biosensor Developers
Table 6.2 Agilent Technologies: Company Overview
Table 6.3 Agilent Technologies: Product Portfolio
Table 6.4 Agilent Technologies: Recent Developments and Future Outlook
Table 6.5 Axion Biosystems: Company Overview
Table 6.6 Axion Biosystems: Product Portfolio
Table 6.7 BioNavigations: Company Overview
Table 6.8 BioNavigations: Product Portfolio
Table 6.9 Creoptix: Company Overview
Table 6.10 Creoptix: Product Portfolio
Table 6.11 Creoptix: Recent Developments and Future Outlook
Table 6.12 Cytiva: Company Overview
Table 6.13 Cytiva: Product Portfolio
Table 6.14 Cytiva: Recent Developments and Future Outlook
Table 6.15 Dynamic Biosensors: Company Overview
Table 6.16 Dynamic Biosensors: Product Portfolio
Table 6.17 Dynamic Biosensors: Recent Developments and Future Outlook
Table 6.18 Malvern Panalytical: Company Overview
Table 6.19 Malvern Panalytical: Product Portfolio
Table 6.20 Malvern Panalytical: Recent Developments and Future Outlook
Table 6.21 Microvacuum: Company Overview
Table 6.22 Microvacuum: Product Portfolio
Table 6.23 Sartorius: Company Overview
Table 6.24 Sartorius: Product Portfolio
Table 6.25 Sartorius: Recent Developments and Future Outlook
Table 6.26 Tempo Bioscience: Company Overview
Table 6.27 Tempo Bioscience: Product Portfolio
Table 8.1 Biosensors in Drug Discovery: List of Funding and Investments, 2018-2022
Table 9.1 Biosensors in Drug Discovery: List of Recent Publications, 2018-2022
Table 10.1 Biosensors in Drug Discovery: List of Global Events, 2021-H2 2023
Table 11.1 Patent Analysis: Prominent CPC Symbols
Table 11.2 Patent Analysis: Most Popular CPC Symbols
Table 11.3 Patent Analysis: List of Top CPC Symbols
Table 11.4 Patent Analysis: Categorization based on Weighted Valuation Scores
Table 11.5 Patent Portfolio: List of Leading Patents (in terms of Highest Relative Valuation)
Table 11.6 Patent Portfolio: List of Leading Patents (in terms of Number of Citations)
Table 14.1 Efferent Labs: Company Snapshot
Table 14.2 Montana Molecular: Company Snapshot
Table 14.2 Domain Therapeutics: Company Snapshot
Table 15.1 Biosensor Developers for Drug Discovery Applications: Distribution by Year of Establishment
Table 15.2 Biosensor Developers for Drug Discovery Applications: Distribution by Company Size
Table 15.3 Biosensor Developers for Drug Discovery Applications: Distribution by Location of Headquarters (Region-wise)
Table 15.4 Biosensor Developers for Drug Discovery Applications: Distribution by Location of Headquarters (Country-wise)
Table 15.5 Biosensor Developers for Drug Discovery Applications: Distribution by Location of Headquarters and Company Size
Table 15.6 Most Active Players: Distribution by Number of Biosensors Developed
Table 15.7 Biosensors in Drug Discovery: Distribution by Type of Biosensor
Table 15.8 Biosensors in Drug Discovery: Distribution by Type of Bioreceptor Used
Table 15.9 Biosensors in Drug Discovery: Distribution by Type of Biosensor and Type of Bioreceptor Used
Table 15.10 Biosensors in Drug Discovery: Distribution by Drug Discovery Step(s) Supported
Table 15.11 Biosensors in Drug Discovery: Distribution by Other Applications Supported
Table 15.12 Biosensors in Drug Discovery: Distribution by Type of Analyte
Table 15.13 Biosensors in Drug Discovery: Distribution by Carrier Plate Format
Table 15.14 Biosensors in Drug Discovery: Distribution by Type of Biosensor and Carrier Plate Format
Table 15.15 Biosensors in Drug Discovery: Distribution by Sample Capacity
Table 15.16 Biosensors in Drug Discovery: Distribution by Sample Volume
Table 15.17 Biosensors in Drug Discovery: Distribution by Type of Detection Method Employed
Table 15.18 Biosensors in Drug Discovery: Distribution by Type of System
Table 15.19 Funding and Investment Analysis: Cumulative Year-wise Distribution of Funding Instances, 2018-2022
Table 15.20 Funding and Investment Analysis: Cumulative Year-wise Distribution of Amount Invested, 2018-2022 (USD Million)
Table 15.21 Funding and Investment Analysis: Distribution of Funding Instances by Type of Funding
Table 15.22 Funding and Investment Analysis: Distribution of Amount Invested by Type of Funding (USD Million)
Table 15.23 Funding and Investment Analysis: Distribution of Funding Instances by Type of Biosensor
Table 15.24 Most Active Players: Distribution by Number of Funding Instances
Table 15.25 Most Active Players: Distribution by Amount Invested (USD Million)
Table 15.26 Most Active Investors: Distribution by Number of Funding Instances
Table 15.27 Funding and Investment Analysis: Distribution of Amount Invested by Region (USD Million)
Table 15.28 Funding and Investment Analysis: Distribution of Amount Invested by Country (USD Million)
Table 15.29 Publication Analysis: Distribution by Year of Publication
Table 15.30 Publication Analysis: Distribution by Type of Publication
Table 15.31 Most Popular Journals: Distribution by Number of Publications
Table 15.32 Most Popular Journals: Distribution by Impact Factor
Table 15.33 Publication Analysis: Most Popular Keywords
Table 15.34 Most Active Publisher: Distribution by Number of Publications
Table 15.35 Most Active Affiliated Institutes: Distribution by Number of Publications
Table 15.36 Publication Analysis: Distribution by Geography
Table 15.37 Global Event Analysis: Cumulative Quarterly Trend
Table 15.38 Global Event Analysis: Distribution by Event Platform
Table 15.39 Global Event Analysis: Distribution by Type of Event
Table 15.40 Global Event Analysis: Distribution by Location of Event
Table 15.41 Most Active Organizers: Distribution by Number of Events
Table 15.42 Global Event Analysis: Distribution by Designation of Participants
Table 15.43 Global Event Analysis: Distribution by Affiliated Department of Participants
Table 15.44 Global Event Analysis: Geographical Mapping of Upcoming Events
Table 15.45 Patent Analysis: Distribution by Type of Patent
Table 15.46 Patent Analysis: Distribution by Patent Publication Year
Table 15.47 Patent Analysis: Distribution by Geography
Table 15.48 Patent Analysis: Distribution by CPC Symbols
Table 15.49 Patent Analysis: Distribution by Patents Age
Table 15.50 Patent Analysis: Distribution by Type of Applicant
Table 15.51 Leading Industry Players: Distribution by Number of Patents
Table 15.52 Leading Non-Industry Players: Distribution by Number of Patents
Table 15.53 Leading Individual Assignees: Distribution by Number of Patents
Table 15.54 Biosensors in Drug Discovery: Patent Valuation Analysis
Table 15.55 Global Biosensors in Drug Discovery Market, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 15.56 Biosensors in Drug Discovery Market: Distribution by Type of Biosensor, 2022 and 2035
Table 15.57 Optical Biosensors in Drug Discovery Market, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 15.58 Electrochemical Biosensors in Drug Discovery Market, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 15.59 Thermal Biosensors in Drug Discovery Market, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 15.60 Other Biosensors in Drug Discovery Market, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 15.61 Biosensors in Drug Discovery Market: Distribution by Type of End User, 2022 and 2035
Table 15.62 Biosensors in Drug Discovery Market for Academic and Research Institutions, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 15.63 Biosensors in Drug Discovery Market for Industry Players, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 15.64 Biosensors in Drug Discovery Market: Distribution by Region, 2022 and 2035
Table 15.65 Biosensors in Drug Discovery Market in North America, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 15.66 Biosensors in Drug Discovery Market in Europe, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 15.67 Biosensors in Drug Discovery Market in Asia Pacific, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 15.68 Biosensors in Drug Discovery Market in Latin America, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 15.69 Biosensors in Drug Discovery Market in Middle East and North Africa, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 15.70 Biosensors in Drug Discovery Market in Rest of the World, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
Please reach out to our team for the details.
Source: www.sciencedirect.com/science/article/pii/S2211383522000521